Search Results
Results for: HITACHI DATA SYSTEMS CORP (Save this search)
Number of Results: 308
Portage Awaits CSE Review, Shareholder Vote for Acquisition of SalvaRx
11 October 2018 - Canadian biotechnology company Portage Biotech Inc (CSE: PBT.U) (OTC: PTGEF) continues to await final work toward obtaining shareholder approvals for its acq...

PORTAGE AWAITS CSE REVIEW, SHAREHOLDER VOTE FOR ACQUISITION OF SALVARX
Canadian biotechnology company Portage Biotech Inc (CSE: PBT.U) (OTC: PTGEF) continues to await final work toward obtaining shareholder approvals for its acquisition of 100% o...

PRS REIT Acquires Development Site, PRS Site
24 September 2018 - UK-based closed-ended real estate investment trust PRS REIT (LSE: PRSR) has acquired a development site for the construction of 145 new family rental homes, wit...

SANBIO ACQUIRES PATENT PORTFOLIO FOR MESENCHYMAL STEM CELLS
Japan-based California, US-based pharmaceutical corporation The SanBio Group, a developer of regenerative medicine for neurological disorders, has acquired a patent portfolio regar...

Strat Aero Closes Acquisition of Controlling Stake in GyroMetric
4 September 2018 - UK-based UAV-focused aerospace services company Strat Aero plc (LSE: AERO) has closed the acquisition of a further 228,000 ordinary shares in digital monitoring ...

SanBio Acquires Patent Portfolio for Mesenchymal Stem Cells
4 September 2018 - Japan-based California, US-based pharmaceutical corporation The SanBio Group, a developer of regenerative medicine for neurological disorders, has acquired a pat...

Strat Aero to Acquire Controlling Stake in GyroMetric
23 August 2018 - UK-based UAV-focused aerospace services company Strat Aero plc (LSE: AERO) has reached agreement to acquire a further 228,000 ordinary shares in digital monitoring...

Portage to Acquire Immuno-Oncology Specialist SalvaRx
15 August 2018 - Canadian biotechnology company Portage Biotech Inc (CSE: PBT.U) (OTC: PTGEF) Portage Biotech Inc. has reached a definitive agreement to acquire 100% of immuno...

PORTAGE TO ACQUIRE IMMUNO-ONCOLOGY SPECIALIST SALVARX
Canadian biotechnology company Portage Biotech Inc (CSE: PBT.U) (OTC: PTGEF) Portage Biotech Inc. has reached a definitive agreement to acquire 100% of immuno-oncology special...

You can compare news articles by clicking on the tick buttons
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   >